Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Kambez Hajipouran Benam (Cambridge, United States of America), Kambez Hajipouran Benam, Richard Novak, Remi Villenave, Carolina Lucchesi, Cedric Hubeau, Janna Nawroth, Mariko Hirano-Kobayashi, Thomas C. Ferrante, Youngjae Choe, Rachelle Prantil-Baun, James C. Weaver, Geraldine A. Hamilton, Anthony Bahinski, Donald E. Ingber. Human small airway-on-a-chip: A novel microphysiological system to model lung inflammation, accelerate drug development and enable inhalational toxico-analysis. Eur Respir J 2016; 48: Suppl. 60, 4542

Member's Comments

No comment yet.

Related content which might interest you: Functional Respiratory Imaging as a sensitive biomarker to assess therapeutic interventions in lung diseases Source: International Congress 2015 – Functional and imaging techniques for assessing lung, airway and respiratory muscles Year: 2015 Development of a human COPD model-on-a-chip to mimic disease exacerbation (a small airway-on-a-chip model) Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 A functional imaging study to investigate the relationship between pulmonary inflammation and systemic inflammation in COPD patients Source: International Congress 2016 – From microimaging to functional evaluation of the lung Year: 2016 Neutrophil extracellular traps (NETs) in COPD: A potential novel mechanism for host damage in acute exacerbations Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015 Modeling human pulmonary inflammatory diseases and therapeutic responses in a microfluidic lung airway-on-a-chip Source: International Congress 2015 – New models for treating airway diseases Year: 2015 Modulation of inflammation by benralizumab in eosinophilic airway disease Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016 Tiotropium effects on airway inflammatory events in the cat as an animal model for acute cigarette smoke-induced lung inflammation Source: International Congress 2014 – Animal models: asthma, COPD and beyond Year: 2014 Lung function impairment in adult asthma increases the risk of systemic inflammation Source: International Congress 2015 – Immune aspects of asthma and other airway diseases Year: 2015 Evaluation of the role of inflammation in chronic airways disease (ERICA): Midpoint evaluation Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013 Endothelial microparticles in sputum of COPD patients: A potential biomarker of disease Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 Different response of lung tissue to intravenous acetylated opium Source: International Congress 2015 – Different data in COPD Year: 2015 TSPO a new anti-inflammatory target in the airway of COPD Source: International Congress 2015 – Advances in the future treatment of COPD Year: 2015 Cellular mechanisms underlying CCSP SNP association with chronic airway diseases Source: International Congress 2015 – New models for treating airway diseases Year: 2015 Airway physiology and pathophysiology in severe asthma Source: Eur Respir Mon 2011; 51: 182-188 Year: 2011 Additive layer manufacturing of physiologically realistic patient specific airway models for study of flow modifications in asthma and COPD Source: Annual Congress 2013 –Functional imaging Year: 2013 The role of circulating mitochondrial DNA in modulating airway inflammation of chronic obstructive pulmonary disease Source: International Congress 2014 – Cell biology 2014 Year: 2014 The novel compound Sul-121 inhibits inflammation in experimental models of chronic obstructive pulmonary disease Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 Effects of long term home NIV on lung inflammation in stable COPD Source: Annual Congress 2013 –New evidence for NIV in the chronic setting Year: 2013 ERICA (evaluating the role of inflammation in chronic airways disease): Extrapulmonary manifestations of COPD Source: Annual Congress 2013 –The best abstracts in extra-pulmonary features and pulmonary rehabilitation Year: 2013 New approaches to the understanding of complex chronic lung diseases Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=345 Year: 2006